Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NEOGENOMICS INC Director's Dealing 2018

Mar 1, 2018

32227_dirs_2018-02-28_7d84fe01-e756-488a-a8aa-599b7433dbeb.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2018-02-26

Reporting Person: VAN OORT DOUGLAS M (Chairman and CEO)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-02-26 Stock Option (Right to Buy) $8.03 A 636000 Acquired 2023-02-26 Common Stock (636000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 187500 Indirect
Common Stock 1832985 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (Right to Buy) $7.15 2021-04-20 Common Stock (472527) 472527 Direct
Stock Option (Right to Buy) $7.52 2022-04-28 Common Stock (500000) 500000 Direct
Restricted Stock $0.00 Common Stock (197042) 197042 Direct

Footnotes

F1: Conundrum Capital Partners, LLC is a limited liability partnership 50% owned by Mr. VanOort. Mr. VanOort is a managing partner of Conundrum Capital Partners, LLC

F2: Includes 125,000 shares of restricted stock that the Board of Directors approved and granted on April 15, 2014. The terms of the award call for the stock to vest on the third anniversary of the grant date as long as Mr. Van Oort is still an employee of the Company. This was disclosed in our Quarterly Report on Form 10-Q as filed with the Securities and Exchange Commission on July 29, 2014.

F3: On April 20, 2016, Mr. VanOort was granted 472,527 stock options. These options vest ratably over the first three anniversary dates of the grant date.

F4: On April 28, 2017, Mr. VanOort was granted 500,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.

F5: Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit.

F6: Restricted stock will vest as follows; 65,680 units will vest on May 25, 2018 and 65,681 units will vest on May 25, 2019 and 2020.

F7: These restricted stock units will terminate upon the earliest of death, termination of employment or the last vesting date.

F8: On February 26, 2018, Mr. VanOort was granted 636,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.